ActiPatch(TM) Product Quickly Approaches World-wide Availability
FREDERICK, Md., July 17 /PRNewswire-FirstCall/ -- BioElectronics Corporation (Pink Sheets: BIEL) announces today a new distribution agreement with Piramal Healthcare Limited has been made for distribution of BioElectronic's revolutionary ActiPatch product.
Piramal Healthcare Limited (earlier Nicholas Piramal India Limited) is one of India's largest companies with strong brand management and sales capabilities. PHL has emerged among the leaders in Indian pharma with one of the widest product portfolios in India.
Andrew J. Whelan, CEO of BioElectronics Corporation, explains, "This is an important and significant order for BioElectronics Corporation. We continue to be excited about developing strong sales in the international marketplace. Piramal Healthcare is an aggressive player and the right partner to help us roll our product out into one of the most populous countries in the world."
Dr. Swati Piramal, Director, Piramal Healthcare Ltd., said, "At Piramal we believe that we should care for the world we share and serve. With the Actipatch launch, we are delighted to bring a breakthrough technology to India to offer a cost effective healing solution." Actipatch(TM), the product marketed by BioElectronics Corp. is changing the face of medicine and the way we heal. Recently chosen as "One of 9 Medical Breakthroughs That May Change Your Life," by Medical Headway.com, ActiPatch is fast becoming the treatment of choice for everything in soft tissue injuries including surgical recovery.
ActiPatch is a drug-free wafer thin patch with an embedded battery-operated microchip that delivers weeks of continuous pulsed RF therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, home use method that reduces soft tissue pain and swelling, and accelerates healing.
Piramal Healthcare will distribute
|SOURCE BioElectronics Corporation|
Copyright©2008 PR Newswire.
All rights reserved